ES492255A0 - Procedimiento para preparar aroilimidazol-2-onas - Google Patents

Procedimiento para preparar aroilimidazol-2-onas

Info

Publication number
ES492255A0
ES492255A0 ES492255A ES492255A ES492255A0 ES 492255 A0 ES492255 A0 ES 492255A0 ES 492255 A ES492255 A ES 492255A ES 492255 A ES492255 A ES 492255A ES 492255 A0 ES492255 A0 ES 492255A0
Authority
ES
Spain
Prior art keywords
aroilimidazole
onas
preparing
procedure
preparing aroilimidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES492255A
Other languages
English (en)
Spanish (es)
Other versions
ES8105299A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES492255(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ES8105299A1 publication Critical patent/ES8105299A1/es
Publication of ES492255A0 publication Critical patent/ES492255A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES492255A 1979-06-18 1980-06-09 Procedimiento para preparar aroilimidazol-2-onas Granted ES492255A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4980879A 1979-06-18 1979-06-18
US11920780A 1980-02-07 1980-02-07

Publications (2)

Publication Number Publication Date
ES8105299A1 ES8105299A1 (es) 1981-06-01
ES492255A0 true ES492255A0 (es) 1981-06-01

Family

ID=26727558

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492255A Granted ES492255A0 (es) 1979-06-18 1980-06-09 Procedimiento para preparar aroilimidazol-2-onas

Country Status (20)

Country Link
AT (1) AT375349B (enrdf_load_stackoverflow)
AU (1) AU532783B2 (enrdf_load_stackoverflow)
CA (1) CA1132554A (enrdf_load_stackoverflow)
CH (1) CH646155A5 (enrdf_load_stackoverflow)
DE (1) DE3021792A1 (enrdf_load_stackoverflow)
DK (1) DK160269C (enrdf_load_stackoverflow)
ES (1) ES492255A0 (enrdf_load_stackoverflow)
FR (1) FR2459233A1 (enrdf_load_stackoverflow)
GB (1) GB2055364B (enrdf_load_stackoverflow)
HK (1) HK61486A (enrdf_load_stackoverflow)
HU (1) HU186736B (enrdf_load_stackoverflow)
IE (1) IE50646B1 (enrdf_load_stackoverflow)
IL (1) IL60243A (enrdf_load_stackoverflow)
IT (1) IT1143922B (enrdf_load_stackoverflow)
MY (1) MY8600709A (enrdf_load_stackoverflow)
NL (2) NL193752C (enrdf_load_stackoverflow)
NO (1) NO152841C (enrdf_load_stackoverflow)
NZ (1) NZ193935A (enrdf_load_stackoverflow)
PH (1) PH18683A (enrdf_load_stackoverflow)
SE (2) SE447107B (enrdf_load_stackoverflow)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
ZA822990B (en) * 1981-05-04 1983-03-30 Merrell Dow Pharma 4-oxymethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
US4329471A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4371737A (en) * 1981-05-04 1983-02-01 Merrell Dow Pharmaceuticals Inc. 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones
US4526981A (en) * 1981-05-04 1985-07-02 Merrell Dow Pharmaceuticals Inc. [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates
US4329470A (en) * 1981-05-04 1982-05-11 Merrell Dow Pharmaceuticals Inc. 5-(4-Phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
US4367236A (en) 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
WO2007056457A2 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101772513B (zh) 2007-06-04 2013-11-13 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
HK1220696A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 鸟苷酸环化酶激动剂及其用途
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治療胃腸道病症的組成物
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN114539157B (zh) * 2022-03-03 2023-12-22 曲靖师范学院 一种碘促进氧化法制备4-碘代n-芳基吡唑类化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them

Also Published As

Publication number Publication date
NL193752C (nl) 2000-09-04
SE8501452D0 (sv) 1985-03-25
ATA314280A (de) 1983-12-15
DK160269C (da) 1991-07-22
NL300015I1 (nl) 2000-11-01
NL8003498A (nl) 1980-12-22
DE3021792C2 (enrdf_load_stackoverflow) 1989-08-10
DK160269B (da) 1991-02-18
NO801796L (no) 1980-12-19
IL60243A (en) 1987-01-30
NL193752B (nl) 2000-05-01
MY8600709A (en) 1986-12-31
HK61486A (en) 1986-08-29
NO152841B (no) 1985-08-19
ES8105299A1 (es) 1981-06-01
SE464559B (sv) 1991-05-13
NL300015I2 (nl) 2000-10-02
SE8004253L (sv) 1980-12-19
IT1143922B (it) 1986-10-29
IL60243A0 (en) 1980-09-16
GB2055364B (en) 1983-06-08
IT8048997A0 (it) 1980-06-17
SE447107B (sv) 1986-10-27
FR2459233B1 (enrdf_load_stackoverflow) 1983-09-23
FR2459233A1 (fr) 1981-01-09
NO152841C (no) 1985-11-27
PH18683A (en) 1985-08-29
HU186736B (en) 1985-09-30
NZ193935A (en) 1985-05-31
SE8501452L (sv) 1985-03-25
IE801162L (en) 1980-12-18
DK259080A (da) 1980-12-19
IE50646B1 (en) 1986-06-11
AT375349B (de) 1984-07-25
AU5911880A (en) 1981-01-08
DE3021792A1 (de) 1981-01-22
AU532783B2 (en) 1983-10-13
CH646155A5 (de) 1984-11-15
GB2055364A (en) 1981-03-04
CA1132554A (en) 1982-09-28

Similar Documents

Publication Publication Date Title
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
ES492943A0 (es) Procedimiento para preparar polieteres sililados
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
MX5604E (es) Procedimiento para preparar aril-hidantoina
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
MX6816E (es) Procedimiento para preparar quinolonas
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
AR227284A1 (es) Procedimiento para preparar antraceno-9,10-bis-carbonil-hidrazonas
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
ES489689A0 (es) Procedimiento para preparar compuestos de isotiourea
MX6141E (es) Procedimiento para preparar acil-ureas
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
ES493499A0 (es) Procedimiento para preparar compuestos de 3-metilemazetidina
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina
ES496518A0 (es) Procedimiento para preparar bencil-oximeteres trisustituidos
ES495984A0 (es) Procedimiento para preparar compuestos de 6-metileno-morfi- nano
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
MX6271E (es) Procedimiento para preparar n-ciandalquil haloacetamidas
MX150040A (es) Procedimiento mejorado para preparar 3-metil-ciclopentadecanona